Athira Pharma
ATHA
NASDAQ
IPO2020
about ATHA
Athira Pharma is a biopharmaceutical company focused on developing therapies for rare genetic disorders, with a lead product targeting CLN2 deficiency, a rare condition affecting children that causes progressive neurological decline.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.26 | $8.36 | $6.77 | $16.31M | 51.61M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.68 | n/a | n/a | 0% | 0% | 0% |